Main navigation About Tolmar Science & Innovation Treatments Responsibility Careers News Contact Patient Access Tolmar’s Commitment to Patient Access Tolmar is committed to responsible pricing and making our therapies accessible to patients in need. Our products hold favorable coverage positions across Medicare, Medicaid, state programs and commercial insurance carriers. Tolmar is dedicated to optimizing patient access to ELIGARD® (leuprolide acetate for injectable suspension) through our comprehensive benefit verification services and Patient Assistance Program (PAP). Tolmar Pharmacueticals, Inc. Footer menu Contact Drug Distribution Accreditation – Learn More Media Privacy Policy Site Map Terms & Conditions ©2018-2020 Tolmar Pharmaceuticals, Inc. All rights reserved. TOLMAR, ELIGARD, FENSOLVI and ATRIGEL are trademarks of the TOLMAR group. Third party trademarks, product names, and copyrights belong to their respective owners. Back to Top

Main navigation About Tolmar Science & Innovation Treatments Responsibility Careers News Contact Technology Creating meaningful science-based advances for our partners and the patients they care for. At Tolmar, we seize the opportunity to innovate at every step. From scientific breakthroughs to innovation in patient and office support and services, we strive to bring both traditional genius and modern creativity to our work. This mindset enables Tolmar to continually deliver innovative therapies and inventive solutions tailored for our customers and partners. We believe in the importance of scientific data to better understand and demonstrate the clinical relevance and efficacy of our products. Tolmar actively participates broadly across local, regional and national forums where clinical data is exchanged and discussed. The proprietary ATRIGEL® Delivery System contained within ELIGARD® (leuprolide acetate for injectable suspension) is a unique formulation technology designed to deliver a continuous dose of medicine over an extended period of time. This makes it possible for patients and their physicians to choose the most suitable dosing schedule, while ensuring consistent, predictable delivery of targeted therapy doses. TolmarSync®, our proprietary practice and patient management platform sets a new standard for technology-based solutions that optimize, track, report and manage inventory. TolmarSync integrates our in-office delivered therapies into office practice processes, ensuring optimized product availability and on-time scheduling for patient injections. Tolmar Pharmacueticals, Inc. Footer menu Contact Drug Distribution Accreditation – Learn More Media Privacy Policy Site Map Terms & Conditions ©2018-2020 Tolmar Pharmaceuticals, Inc. All rights reserved. TOLMAR, ELIGARD, FENSOLVI and ATRIGEL are trademarks of the TOLMAR group. Third party trademarks, product names, and copyrights belong to their respective owners. Back to Top